Tranzyme Pharma (TZYM)/Norgine GI Drug Fails Second Late-stage Trial
5/28/2012 11:17:24 PM
More...
|
Tranzyme Pharma (TZYM) and Norgine Bowel Drug Fails Trial
3/12/2012 6:58:33 AM
More...
|
Tranzyme Pharma and Norgine Complete Enrollment in ULISES 008, the Second of Two Phase 3 Pivotal Trials of Ulimorelin
2/28/2012 9:35:14 AM
More...
|
APR Applied Pharma Research S.A., Labtec GmbH and Norgine Announce the Signature of an Exclusive Licensing Agreement Under Which Norgine will Market and Distribute Setofilm™
1/18/2012 6:18:01 AM
More...
|
Pharma Firm Norgine Plans 36 Job Losses
1/6/2012 8:12:30 AM
More...
|
Tranzyme Pharma and Norgine Complete Enrollment in First of Two Pivotal Phase 3 Trials of Ulimorelin
12/7/2011 9:50:06 AM
More...
|
Norgine and Jubilant BioSys Ltd. Announce Discovery Collaboration in Gastrointestinal Therapeutic Area
10/18/2011 6:19:34 AM
More...
|
Tranzyme Pharma and Norgine Initiate Dosing in Phase 3 Pivotal Study of Novel Intravenous GI Motility Drug Ulimorelin
2/23/2011 8:50:19 AM
More...
|
Drug Company ProStrakan Group Considers Takeover Approach; Already Rejected Norgine Offer but Considering Others Now
11/16/2010 7:33:31 AM
More...
|
Meda AB (MDABF.PK) Acquires OTC Products From Norgine
11/11/2010 10:27:33 AM
More...
|
|